EGEN-2784
Intervention1 paper2 findings
- Human trial1
Outcomes
2Allosensitisation
no changein humans1Very low certainty
1 study
Allosensitisation
no changein humans1Very low certainty
EGEN-2784 has no effect on allosensitisation in humans.
Human trialfollowing explantation of porcine xenograft EGEN-2784kidney231 days of follow-up
Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study · Lancet (London, England) · 3 Sep 2026
Dialysis independence
upin humans1Very low certainty
1 study
Dialysis independence
upin humans1Very low certainty
EGEN-2784 improves dialysis independence in humans (271 days).
Human trialin a patient with end-stage kidney diseasekidney271 days
Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study · Lancet (London, England) · 3 Sep 2026